Fortrea Holdings Inc.
Organization details
- Legal name
- Fortrea Holdings Inc.
- Former names
- Silver Spinco Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Headquarters city
- Durham
- Headquarters state / province
- North Carolina
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- FTRE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001965040
- EIN
- 92-2796441
Board of directors
-
Amrit Ray · DirectorSince 2023
-
Anshul Thakral · Director · Chief Executive OfficerSince 2025
-
Betty D. Larson · DirectorSince 2023
-
David Ross Smith · Director · Interim CFOSince 2023
-
Der Vaart Sandra D. Van · Director · President and SecretarySince 2023
-
Edward A. Pesicka · DirectorSince 2023
-
Erin L. Russell · DirectorSince 2025
- Since 2023
-
Machelle Sanders · DirectorSince 2024
-
Peter M. Neupert · Director · Chief Executive OfficerSince 2023
-
R. Andrew Eckert · DirectorSince 2023
-
Thomas Pike · Director · Chief Executive OfficerSince 2024
-
William J. Sharbaugh · DirectorSince 2025
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 44
1% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Director election results
Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.2%
-
96.6%
-
96.7%
Board connections
8 of this board's directors also sit on 14 other boards. 9 are in the same sector.
- via Edward A. Pesicka
-
Adaptive Biotechnologies Corporation Same sectorvia Peter M. Neupert
-
Becton Dickinson and Company Same sectorvia R. Andrew Eckert
-
BioCryst Pharmaceuticals Inc. Same sectorvia Machelle Sanders
- via Erin L. Russell
-
Labcorp Holdings Inc. Same sectorvia Peter M. Neupert
-
Lumexa Imaging Holdings Inc. Same sectorvia Glenn A. Eisenberg
-
Maravai LifeSciences Holdings Inc. Same sectorvia R. Andrew Eckert
- via Thomas Pike
-
MiniMed Group Inc. Same sectorvia Glenn A. Eisenberg
-
Solventum Corporation Same sectorvia Glenn A. Eisenberg
- via Glenn A. Eisenberg
-
Ultragenyx Pharmaceutical Inc. Same sectorvia Amrit Ray
- via Erin L. Russell
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $4,683,483
- 24 sales by 6 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Morais Mark A. Officer (Chief Operating Officer) | Open-market sale | −3,149 | $16.85 | $53,061 |
| Sep 9, 2026 | Russell Carrie Elizabeth Officer (Interim CAO) | Open-market sale | −246 | $16.85 | $4,145 |
| Sep 8, 2026 | Morais Mark A. Officer (Chief Operating Officer) | Option exercise | +7,157 | — | — |
| Sep 8, 2026 | Russell Carrie Elizabeth Officer (Interim CAO) | Option exercise | +850 | — | — |
| Aug 19, 2026 | Morais Mark A. Officer (Chief Operating Officer) | Open-market sale | −4,892 | $18.19 | $88,985 |
| Aug 18, 2026 | Morais Mark A. Officer (Chief Operating Officer) | Option exercise | +11,313 | — | — |
| Aug 6, 2026 | Anshul Thakral Director, Officer (Chief Executive Officer) | Open-market sale | −55,882 | $18.17 | $1,015,376 |
| Aug 6, 2026 | Anshul Thakral Director, Officer (Chief Executive Officer) | Open-market sale | −55,975 | $18.06 | $1,010,909 |
| Aug 5, 2026 | Anshul Thakral Director, Officer (Chief Executive Officer) | Open-market sale | −49,452 | $19.03 | $941,072 |
| Aug 5, 2026 | Anshul Thakral Director, Officer (Chief Executive Officer) | Open-market sale | −50,417 | $19.28 | $972,040 |
| Aug 4, 2026 | Anshul Thakral Director, Officer (Chief Executive Officer) | Option exercise | +416,666 | — | — |
| Aug 3, 2026 | Machelle Sanders Director | Open-market sale | −9,700 | $18.01 | $174,697 |
| Jul 20, 2026 | David Ross Smith Director | Option exercise | +6,598 | — | — |
| Jun 10, 2026 | Machelle Sanders Director | Option exercise | +38,817 | — | — |
| Jun 10, 2026 | David Ross Smith Director | Option exercise | +38,817 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Fortrea Holdings Inc.
Who is the CEO of Fortrea Holdings Inc.?
Anshul Thakral has been Fortrea Holdings Inc.'s Chief Executive Officer since August 2025.
How many directors are on Fortrea Holdings Inc.'s board?
Fortrea Holdings Inc.'s board has 13 directors: Amrit Ray, Anshul Thakral, Betty D. Larson, David Ross Smith, Der Vaart Sandra D. Van, Edward A. Pesicka, Erin L. Russell, Glenn A. Eisenberg, Machelle Sanders, Peter M. Neupert and 3 others.
Are Fortrea Holdings Inc. insiders buying or selling shares?
Over the last 12 months, Fortrea Holdings Inc. insiders made no open-market purchases and sold $4.7 million of shares in 24 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="fortrea-holdings-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.